Deciphera Pharmaceuticals announced that it intends to offer and sell $125M of shares of its common stock in an underwritten public offering. J.P. Morgan, Jefferies, Cowen, and Guggenheim Securities are acting as joint book-running managers for the offering.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on DCPH:
